Kforce (KFRC) to Sell $50M of Clinical Research Shares

Kforce Inc. (Nasdaq: KFRC), has entered into a Stock Purchase Agreement with inVentiv Health, Inc. dated March 17, 2012 to sell all of the issued and outstanding shares of capital stock of Kforce Clinical Research, Inc. for an aggregate purchase price of $50 million in cash. Kforce expects the transaction to close at the end of March, subject to customary closing conditions.

Robert W. Baird and Company is acting as advisor to Kforce Inc. on this transaction.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Hennessy VII shareholders approve merger with ONE Nuclear
• Schneider marks 3 years since M&M Transport acquisition
• Callan JMB names Andy Weigman SVP for oil and gas unit